Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
291 Results Found
Cybersecurity In Health Care | AHA Affinity Forum
Join the AHA and Censinet for a 3-part series of interactive virtual panel discussions on key aspects of cybersecurity in health care.
Meet our Preferred Cybersecurity Providers | Cybersecurity | Center
Our cyber adversaries are agnostic and collaborative in their approach — they assist each other to develop and launch malware and ransomware attacks against health care.
AHA Preferred Cybersecurity Provider | Center
The AHA has created a panel of a limited number of highly-reputable and qualified cybersecurity service providers to support AHA member hospitals and health systems with their cyber defense programs. The AHA Preferred Cybersecurity Provider (APCP) Program will assist AHA members by directing them to firms that provide exceptional value in terms of pricing and quality for cybersecurity services.
Webinar: How Does that Apply to Us? FHA, ADA and Senior Living Providers
Join our webinar to gain profound insights into the often overlooked impact of Fair Housing Act (FHA) and American with Disabilities Act (ADA) on diverse senior living providers.
Correctional Health Care Risks, Trends and Safety Concerns
Discover actionable insights to address the distinctive patient safety challenges and tap into significant public health opportunities presented by individuals in the correctional system.
Webinar: Reducing Risk in Maternal Care: The Power of Personalizing Competency Development
Join Trisha Coady as she reviews the impact personalizing competency development and Artificial Intelligence can have on adverse events through an obstetric lens.
Webinar: Practical Application of Proactive Safety: Evolving Our Approach
Join Dr. Brent Lee and Jenna Merandi as they outline how modern approaches can reduce patient harm.
ASHE ICRA 2.0™ Training Program
This train-the-trainer program provides health care facilities with the tools to train and onboard new staff to complete ASHE's ICRA 2.0™ process and personalize the strategy for your individual site.
FDA withdraws accelerated approval of myeloma drug
The Food and Drug Administration Feb. 23 withdrew approval of Pepaxto (melphalan flufenamide), a drug once used with dexamethasone to treat certain U.S. patients with multiple myeloma, because a post-approval trial did not show it safe or effective.